Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1411 results found. Search for [ emergency use ]

Results 1 to 21 of 1411
India Today Tech
New Delhi, March 1, 2021
Cybersecurity company, Recorded Future, notified the Indian government about the China-linked threat activity group, RedEcho, which may have been responsible for the Mumbai power outage.


Reuters
March 1, 2021
AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca-Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added


PTI
February 28, 2021
The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations, and death


Associated Press
February 27, 2021
The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US


PTI
February 26, 2021
The Food and Drug Administration said Thursday that it's allowing the additional option after reviewing new data from New York-based Pfizer and its German partner, BioNTech


Rashi Bisaria
New Delhi, February 25, 2021
Johnson & Johnson's single-dose COVID-19 vaccine effective, safe: FDA Drug maker Johnson & Johnson's single-shot COVID-19 vaccine is safe and effective as per the data submitted from its ongoing multi-national Phase 3 randomised, double-blind and placebo-controlled trials. This is what a  briefing document published by the US Food and Drug Administration (FDA) has said. Johnson & Johnson had sought emergency use authorisation for its vaccine on February 4. FDA's advisory co...


BusinessToday.In
February 25, 2021
The real-world study involved around 1.2 million people in Israel. Pfizer vaccine has also proved to be effective against B.1.1.7 variant, also known as the UK variant of coronavirus


PTI
February 25, 2021
Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume


BusinessToday.In
February 24, 2021
The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilised variant of the SARS-CoV-2 S protein.


BusinessToday.In
February 23, 2021
The approval to the vaccine without phase-3 efficacy data had drawn severe criticism with the government reiterating its stand that the vaccine was safe to use


PTI
February 22, 2021
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support


PB Jayakumar
February 22, 2021
The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore


PB Jayakumar
February 19, 2021
The Government is yet to finalise a strategy for vaccinating 27 crore elderly in India in the next phase. The Government target was to vaccinate over three million people per day


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


BusinessToday.In
February 19, 2021
India's ambitious vaccination campaign which has already covered over 1 crore healthcare workers, aims to cover 30 crore people by August


BusinessToday.In
February 18, 2021
Bharat Biotech is in the process of filing regulatory documents for approval of its vaccine, Covaxin, in more than 40 countries


Team BT
New Delhi, February 18, 2021
Leading experts explain how supply chain dynamics are critical to achieving targets


Reuters
Sydney, February 18, 2021
Facebook's move was swiftly criticised by news producers, politicians and human rights advocates in Australia.


PTI
February 17, 2021
The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)


BusinessToday.In
February 17, 2021
National Intelligence Service (NIS), the chief intelligence agency of South Korea informed lawmakers about the alleged cyber breach on Tuesday, February 16, during a closed-door briefing to a parliamentary intelligence committee


PAGES 1 OF 71  12345